WO2023139536 - (4-PIPERAZIN-1YL)-4-ALKYL-PHTHALAZIN-1(2H)-ONE COMPOUNDS AS PARP7 INHIBITORS
National phase entry is expected:
Publication Number
WO/2023/139536
Publication Date
27.07.2023
International Application No.
PCT/IB2023/050507
International Filing Date
20.01.2023
Title **
[English]
(4-PIPERAZIN-1YL)-4-ALKYL-PHTHALAZIN-1(2H)-ONE COMPOUNDS AS PARP7 INHIBITORS
[French]
COMPOSÉS (4-PIPÉRAZIN-1YL)-4-ALKYL-PHTALAZIN-1(2H)-ONE EN TANT QU'INHIBITEURS DE PARP7
Applicants **
RHIZEN PHARMACEUTICALS AG
INCOZEN THERAPEUTICS PVT. LTD.
Inventors
VAKKALANKA, Swaroop Kumar Venkata Satya
BHUNIYA, Debnath
ELESWARAPU, Venkata Satyanarayana
BABU, Govindarajulu
Priority Data
202241003918
24.01.2022
IN
202241025747
03.05.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5851 | |
| EPO | Filing, Examination, Granting | 91082 | |
| Japan | Filing, Examination, Granting | 4749 | |
| South Korea | Filing, Examination, Granting | 6944 | |
| USA | Filing, Examination, Granting | 62690 |
Total:
171,316
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention provides compounds of formula (I) as poly(ADP-ribose) polymerase 7 (PARP7) inhibitors, methods of preparing them, pharmaceutical compositions containing them and their use in methods of treatment, prevention and/or amelioration of diseases or disorders involving PARP7.[French]
La présente invention concerne des composés de formule (I) utilisés comme inhibiteurs de poly(ADP-ribose) polymérase 7 (PARP7), des méthodes de préparation de ceux-ci, des compositions pharmaceutiques les contenant et leur utilisation dans des méthodes de traitement, de prévention et/ou d'atténuation de maladies ou de troubles impliquant PARP7.